Journal
PHARMACEUTICS
Volume 12, Issue 12, Pages -Publisher
MDPI
DOI: 10.3390/pharmaceutics12121193
Keywords
neoadjuvant therapy; treatment resistance; siRNA nanoparticles; liposomal nanostructures
Categories
Funding
- Sao Paulo State Research Foundation [2019/24079-1, 2019/24001-2]
Ask authors/readers for more resources
Breast cancer (BC) is one of the most important cancers worldwide, and usually, chemotherapy can be used in an integrative approach. Usually, chemotherapy treatment is performed in association with surgery, radiation or hormone therapy, providing an increased outcome to patients. However, tumors can develop resistance to different drugs, progressing for a more aggressive phenotype. In this scenario, the use of nanocarriers could help to defeat tumor cell resistance, providing a new therapeutic perspective for patients. Thus, this systematic review aims to bring the molecular mechanisms involved in BC chemoresistance and extract from the previous literature information regarding the use of nanoparticles as potential treatment for chemoresistant breast cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available